Constitution of Cerebrospinal Fluid and Blood Database/Specimen in Acute Stage of Subarachnoid Hemorrhage (aSAH) Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2011 by University of Regensburg.
Recruitment status was Recruiting
Recruitment status was Recruiting
Sponsor:
University of Regensburg
Collaborator:
Technische Universität München
Information provided by:
University of Regensburg
ClinicalTrials.gov Identifier:
NCT01292278
First received: February 8, 2011
Last updated: NA
Last verified: January 2011
History: No changes posted
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Neuropeptide Y (NPY) may play a major role in the pathophysiology of aneurysmal subarachnoid hemorrhage (aSAH). To investigate the correlation of NPY in cerebrospinal fluid (CSF) and blood (serum) and the neurological outcome in the acute stage of aSAH.
| Condition |
|---|
|
Subarachnoid Hemorrhage |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Prospective |
| Official Title: | The Possible Role of Neuropeptide Y After Spontaneous Subarachnoid Hemorrhage |
Further study details as provided by University of Regensburg:
Biospecimen Retention: Samples Without DNA
cerebrospinal fluid / serum
| Estimated Enrollment: | 90 |
| Study Start Date: | January 2006 |
| Estimated Study Completion Date: | December 2011 |
| Estimated Primary Completion Date: | August 2011 (Final data collection date for primary outcome measure) |
| Groups/Cohorts |
|---|
|
aSAH
consecutive patients with spontaneous or aneurysmal subarachnoid hemorrhage
|
|
control group
no neurological disease but spinal anesthesia
|
Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Probability Sample |
Study Population
consecutive pts. with subarachnoid hemorrhage
Criteria
Inclusion Criteria:
- spontaneous or aneurysmal subarachnoid hemorrhage
Exclusion Criteria:
- age younger than 18 years or older than 70 years
- inflammatory disease
- history of former SAH
- no ventricular drainage
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01292278
Locations
| Germany | |
| Department of Neurosurgery Medical Center University of Regensburg | Recruiting |
| Regensburg, Germany, 93053 | |
| Contact: Karl-Michael Schebesch, M.D. ++49 +941 944 9010 karl-michael.schebesch@klinik.uni-regensburg.de | |
| Principal Investigator: Karl-Michael Schebesch, M.D. | |
Sponsors and Collaborators
University of Regensburg
Technische Universität München
More Information
No publications provided
| Responsible Party: | Alexander Brawanski M.D., Ph.D., University of Regensburg |
| ClinicalTrials.gov Identifier: | NCT01292278 History of Changes |
| Other Study ID Numbers: | CSF 06/179 |
| Study First Received: | February 8, 2011 |
| Last Updated: | February 8, 2011 |
| Health Authority: | Germany: The Bavarian State Ministry of the Environment and Public Health |
Keywords provided by University of Regensburg:
|
subarachnoid hemorrhage cerebral vasospasm neuropeptide Y spontaneous aneurysmal |
Additional relevant MeSH terms:
|
Hemorrhage Subarachnoid Hemorrhage Pathologic Processes Intracranial Hemorrhages Cerebrovascular Disorders |
Brain Diseases Central Nervous System Diseases Nervous System Diseases Vascular Diseases Cardiovascular Diseases |
ClinicalTrials.gov processed this record on May 16, 2013